LBX Pharmacy Chain Joint Stock Company (603883.SS)
CNY 18.99
(1.77%)
CNY 18.99
(1.77%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.39 Billion CNY | 19.09% |
| 2022 | 1.2 Billion CNY | 26.17% |
| 2021 | 956.46 Million CNY | -0.32% |
| 2020 | 959.51 Million CNY | 25.42% |
| 2019 | 765.06 Million CNY | 21.66% |
| 2018 | 628.85 Million CNY | 28.78% |
| 2017 | 488.31 Million CNY | 19.83% |
| 2016 | 407.51 Million CNY | 17.02% |
| 2015 | 348.23 Million CNY | 15.13% |
| 2014 | 302.48 Million CNY | 22.09% |
| 2013 | 247.75 Million CNY | 20.64% |
| 2012 | 205.36 Million CNY | 26.26% |
| 2011 | 162.65 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 302.9 Million CNY | -37.95% |
| 2024 Q1 | 488.19 Million CNY | 40.06% |
| 2024 Q3 | 213.54 Million CNY | -29.5% |
| 2023 Q2 | 340.88 Million CNY | -18.15% |
| 2023 FY | 1.43 Billion CNY | 19.09% |
| 2023 Q4 | 348.57 Million CNY | 13.23% |
| 2023 Q3 | 307.83 Million CNY | -9.7% |
| 2023 Q1 | 416.47 Million CNY | 20.55% |
| 2022 Q1 | 321.72 Million CNY | 52.54% |
| 2022 FY | 1.2 Billion CNY | 26.17% |
| 2022 Q4 | 345.47 Million CNY | -0.52% |
| 2022 Q3 | 347.28 Million CNY | -22.79% |
| 2022 Q2 | 449.79 Million CNY | 39.81% |
| 2021 Q4 | 210.91 Million CNY | 21.69% |
| 2021 Q2 | 254.7 Million CNY | -19.79% |
| 2021 Q1 | 317.52 Million CNY | 58.12% |
| 2021 Q3 | 173.31 Million CNY | -31.95% |
| 2021 FY | 956.46 Million CNY | -0.32% |
| 2020 Q3 | 230.93 Million CNY | 0.23% |
| 2020 Q1 | 297.37 Million CNY | 59.05% |
| 2020 Q2 | 230.39 Million CNY | -22.52% |
| 2020 FY | 959.51 Million CNY | 25.42% |
| 2020 Q4 | 200.8 Million CNY | -13.05% |
| 2019 Q3 | 173.07 Million CNY | -0.26% |
| 2019 Q2 | 173.52 Million CNY | -25.05% |
| 2019 Q1 | 231.5 Million CNY | 42.16% |
| 2019 FY | 765.06 Million CNY | 21.66% |
| 2019 Q4 | 186.96 Million CNY | 8.03% |
| 2018 Q3 | 136.57 Million CNY | -7.51% |
| 2018 FY | 628.85 Million CNY | 28.78% |
| 2018 Q4 | 162.84 Million CNY | 19.24% |
| 2018 Q1 | 181.78 Million CNY | 37.73% |
| 2018 Q2 | 147.66 Million CNY | -18.77% |
| 2017 Q1 | 152.49 Million CNY | 23.82% |
| 2017 FY | 488.31 Million CNY | 19.83% |
| 2017 Q4 | 131.98 Million CNY | 24.54% |
| 2017 Q3 | 105.97 Million CNY | 8.28% |
| 2017 Q2 | 97.86 Million CNY | -35.82% |
| 2016 Q2 | 86.87 Million CNY | -17.62% |
| 2016 Q4 | 123.15 Million CNY | 33.84% |
| 2016 FY | 407.51 Million CNY | 17.02% |
| 2016 Q1 | 105.46 Million CNY | -3.96% |
| 2016 Q3 | 92.01 Million CNY | 5.91% |
| 2015 Q4 | 109.81 Million CNY | 67.3% |
| 2015 Q2 | 77.95 Million CNY | -17.79% |
| 2015 Q1 | 94.82 Million CNY | -2.02% |
| 2015 Q3 | 65.63 Million CNY | -15.8% |
| 2015 FY | 348.23 Million CNY | 15.13% |
| 2014 Q2 | 68.1 Million CNY | -17.21% |
| 2014 Q4 | 96.77 Million CNY | 74.92% |
| 2014 Q3 | 55.32 Million CNY | -18.77% |
| 2014 FY | 302.48 Million CNY | 22.09% |
| 2014 Q1 | 82.26 Million CNY | 0.0% |
| 2013 FY | 247.75 Million CNY | 20.64% |
| 2012 FY | 205.36 Million CNY | 26.26% |
| 2011 FY | 162.65 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Shanghai No.1 Pharmacy Co., Ltd. | 98.95 Million CNY | -1312.905% |
| Jointown Pharmaceutical Group Co., Ltd | 3.96 Billion CNY | 64.715% |
| Yifeng Pharmacy Chain Co., Ltd. | 2.05 Billion CNY | 31.957% |
| Yunnan Jianzhijia Health-Chain Co., Ltd. | 639.62 Million CNY | -118.587% |